Aviceda Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(617) 225-4343Website
www.avicedarx.comRevenue
<$5 MillionIndustry
About Aviceda Therapeutics
Aviceda Therapeutics is a leading company in glyco-immune checkpoint therapeutics, focusing on developing innovative immune-mediated therapies. Their primary aim is to enhance the quality of life for patients suffering from immune-mediated diseases, with a particular emphasis on treating Macular Degeneration, a significant cause of blindness. The company is dedicated to advancing novel treatments that address critical health challenges. Aviceda Therapeutics targets patients in need of effective therapies for immune-related conditions.Explore more
Aviceda Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aviceda Therapeutics
Compare insights from companies similar to Aviceda Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aviceda Therapeutics
<$5M
11-50
Private
$213.8M
2018
KS
Kristen StrifflerVice President, Clinical Operations
Aviceda Therapeutics Tech Stack
A closer look at the technologies used by Aviceda Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aviceda Therapeutics
Sign Up For FreeTo access detailed company insights
Aviceda Therapeutics is a leading company in glyco-immune checkpoint therapeutics, focusing on developing innovative immune-mediated therapies. Their primary aim is to enhance the quality of life for patients suffering from immune-mediated diseases, with a particular emphasis on treating Macular Degeneration, a significant cause of blindness. The c... Read More
